drugset / Trial / NCT04343547
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate drug-drug interaction by comparing the pharmacokinetics (PK)/pharmacodynamics (PD), safety, and tolerability of single/multiple doses of DWP16001 , DWC202001 and DWC202002 alone or in combination in healthy male adults.
Timeline
- Start
- 2020-04
- Primary completion
- 2020-07
- Completion
- 2020-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWC202001 | Unknown | — | Oral |
| Subject | DWC202002 | Unknown | — | Oral |
| Subject | Enavogliflozin | Small molecule | — | Oral |
Indications
No indication recorded.